SynthesisInternational urology and nephrology2025
Association of estimated glomerular filtration rate with proliferative diabetic retinopathy: a systematic review and meta-analysis.
Synthesis in International urology and nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Construction and Validation of a Long-Term Visual Prognosis Prediction Model for Proliferative Diabetic Retinopathy After Vitrectomy Based on Machine Learning.Endocrinology, diabetes & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProliferative diabetic retinopathy (PDR) is a serious vision-threatening complication of diabetes. Chronic kidney disease (CKD), measured by estimated glomerular filtration rate (eGFR), shares similar pathophysiological mechanisms with diabetic retinopathy, including inflammation, oxidative stress, and vascular dysfunction. However, the strength of the association between eGFR and PDR remains unclear. This review evaluates the association between reduced eGFR and the risk of PDR in individuals with diabetes.
methodsA comprehensive literature search was conducted in PubMed, Embase, and Web of Science, from inception to October 2024. Observational studies reporting both eGFR values and PDR status were included. Study quality was assessed using the Newcastle-Ottawa Scale. Pooled standardized mean differences (SMD) were calculated using a fixed-effects model when heterogeneity was low (I
resultsA total of 11 studies were included, comprising 602 patients with PDR and 5,475 individuals without diabetic retinopathy. The pooled SMD for eGFR between PDR and non-PDR groups was - 0.43 (95% CI - 0.52 to - 0.34; P < 0.0001), indicating significantly lower eGFR in PDR patients. Heterogeneity was moderate (I
conclusionsThis systematic review and meta-analysis found a significant association between reduced eGFR and PDR in patients with diabetes, with consistent findings across studies and eGFR estimation methods. Though heterogeneity suggests caution in interpretation. Additional prospective using standardized methodologies are needed to clarify causality and enhance risk prediction.
Indexed as
Identifiers
40319431What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.